Syndax Pharmaceuticals, Inc. (SNDX)
9.54
+0.17
(+1.81%)
USD |
NASDAQ |
Nov 06, 16:00
9.79
+0.25
(+2.62%)
After-Hours: 20:00
Syndax Pharmaceuticals Market Cap : 858.50M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 858.50M |
| November 05, 2026 | 843.20M |
| November 04, 2026 | 940.39M |
| November 03, 2026 | 1.286B |
| November 02, 2026 | 1.179B |
| October 30, 2026 | 1.228B |
| October 29, 2026 | 1.273B |
| October 28, 2026 | 1.277B |
| October 27, 2026 | 1.220B |
| October 26, 2026 | 1.179B |
| October 23, 2026 | 1.195B |
| October 22, 2026 | 1.210B |
| October 21, 2026 | 1.172B |
| October 20, 2026 | 1.181B |
| October 19, 2026 | 1.167B |
| October 16, 2026 | 1.150B |
| October 15, 2026 | 1.217B |
| October 14, 2026 | 1.206B |
| October 13, 2026 | 1.244B |
| October 12, 2026 | 1.475B |
| October 09, 2026 | 1.515B |
| October 08, 2026 | 1.507B |
| October 07, 2026 | 1.518B |
| October 06, 2026 | 1.549B |
| October 05, 2026 | 1.590B |
| Date | Value |
|---|---|
| October 02, 2026 | 1.569B |
| October 01, 2026 | 1.624B |
| September 30, 2026 | 1.676B |
| September 29, 2026 | 1.626B |
| September 28, 2026 | 1.592B |
| September 25, 2026 | 1.623B |
| September 24, 2026 | 1.602B |
| September 23, 2026 | 1.573B |
| September 22, 2026 | 1.621B |
| September 21, 2026 | 1.611B |
| September 18, 2026 | 1.571B |
| September 17, 2026 | 1.576B |
| September 16, 2026 | 1.541B |
| September 15, 2026 | 1.613B |
| September 14, 2026 | 1.636B |
| September 11, 2026 | 1.621B |
| September 10, 2026 | 1.678B |
| September 09, 2026 | 1.769B |
| September 08, 2026 | 1.778B |
| September 04, 2026 | 1.833B |
| September 03, 2026 | 1.844B |
| September 02, 2026 | 1.853B |
| September 01, 2026 | 1.792B |
| August 31, 2026 | 1.720B |
| August 28, 2026 | 1.742B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.654B |
| Emergent BioSolutions, Inc. | 310.88M |
| Incyte Corp. | 24.41B |
| Vertex Pharmaceuticals, Inc. | 138.70B |
| Travere Therapeutics, Inc. | 4.745B |
Market Cap Related Metrics
| PS Ratio | 2.918 |
| Price | 9.54 |
| Earnings Yield | -24.81% |